S&P 500 7,580.07 −1.82%
Nasdaq 25,437.00 −2.86%
S&P/TSX 35,620.03 −1.74%
Apple 344.63 −1.23%
Nvidia 204.64 −4.22%
Microsoft 521.91 −1.55%
Shopify 220.37 −5.70%
Royal Bank 283.93 −1.49%
CAD/USD 0.7153 +0.04%
CLOSED · 01:50 ET
Market ClerkRecap
Mon Nov 2 · markets closed1 signal on Oct 31129 insider buys this week · $10BCIRO short report next: Nov 14The week ahead
RW
INSIDER · TVTX · Travere Therapeutics, Inc. · CHIEF RESEARCH OFFICER

ROTE WILLIAM E.

Every open-market transaction filed under this name, Sep 15 to Sep 16.

Filings
6
0 buys · 6 sells
Bought
—
open market, at cost
Sold
$13.1M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 16TVTXTravere Therapeutics, Inc.Chief Research OfficerSell47,746$63.61$3M−17.6%
Sep 16TVTXTravere Therapeutics, Inc.Chief Research OfficerSell65,104$63.12$4.1M−16.9%
Sep 15TVTXTravere Therapeutics, Inc.Chief Research OfficerSell270$65.31$18K−19.7%
Sep 15TVTXTravere Therapeutics, Inc.Chief Research OfficerSell3,000$63.65$191K−17.6%
Sep 15TVTXTravere Therapeutics, Inc.Chief Research OfficerSell29,021$62.66$1.8M−16.3%
Sep 15TVTXTravere Therapeutics, Inc.Chief Research OfficerSell63,907$61.99$4M−15.4%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.